Back

Effects on albuminuria and blood pressure after radiofrequency renal denervation: two-year results from the Global SYMPLICITY Registry DEFINE

31 August 2026 (13:35 - 13:45)
Organised by: Logo
Congress Presentation Part of: Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Markus Schlaich

Royal Perth Hospital - University of Western Australia, Perth (Australia)

5 More presentations in this session

Presentation thumbnail
Cardiorenal syndrome in German primary care: real-world diagnostics and SGLT2 Inhibitor use
Associate Professor S. Wassmann (Munich, DE)
Abstract Slides Video
Presentation thumbnail
PEN2 stabilizes SLC25A51 to inhibit vascular calcification through NAD+ redistribution between mitochondrion and nucleus
Assistant Professor B. Dong (CN)
Abstract Slides Video
Presentation thumbnail
Association of the non–lipoprotein(a) apolipoprotein b–to–lipoprotein(a) ratio with renal dysfunction in cardiovascular disease patients: implications for atherosclerotic burden and prognosis
Doctor K. Yamamoto (JP)
Abstract Slides Video
Presentation thumbnail
Nationwide 5-year outcomes in U.S. dialysis patients with failed bioprosthetic surgical AVR: valve-in-valve TAVR versus redo surgery
Doctor M. Tagliafierro (New York, US)
Abstract Slides Video
Presentation thumbnail
Clinical profile and determinants of NECPAL positivity in advanced cardiorenal syndrome: a prospective multicentre study
Doctor I. Navarro-Pelayo Torres (Granada, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 13:35 CET
You may be interested in
thumbnail
Congress Presentation
Blood pressure and renal function changes in patients with severe chronic kidney disease undergoing radiofrequency renal denervation: 12 months outcomes from the Global SYMPLICITY Registry DEFINE
30 August 2024
thumbnail
Congress Session
Hypertension epidemiology: risk and outcomes
30 August 2026
thumbnail
Congress Presentation
Renal denervation improves metabolic parameters and reduces SCORE2-estimated cardiovascular risk in uncontrolled hypertension
28 August 2026
thumbnail
Congress Presentation
Which drugs to select and which to avoid in a patient with microalbuminuria
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources